Department of Rehabilitation Sciences, The Hong Kong Polytechnic University, Hong Kong.
School of Nursing, The Hong Kong Polytechnic University, Hong Kong.
Biomed Res Int. 2018 Dec 20;2018:6985963. doi: 10.1155/2018/6985963. eCollection 2018.
This study aimed to (1) investigate the interrater, intrarater, and test-retest reliabilities, as well as the minimal detectable change, of the Maximal Step Length test (MSL) in stroke survivors, (2) examine the concurrent validity of MSL with other stroke-specific impairment measurements in stroke survivors, and (3) compare the MSL performances of stroke survivors and those of age-matched healthy older adults in different directions.
Cross-sessional study.
University-based research laboratory.
Stroke survivors (n = 48) and age-matched healthy older adults (n = 39).
Stroke survivors were assessed with MSL, lower limb muscle strength, Limits of Stability (LOS) Test, Berg Balance Scale (BBS), 5-meter walk test, and Activities-specific Balance Confidence (ABC) scale by two trained assessors in 1 session. Their performance on MSL was reassessed 1 week later to establish the test-retest reliability. Healthy older adults were assessed with MSL only. Intraclass correlation coefficient (ICC) was used to assess the reliability of MSL and Spearman's rho was used to quantify the strength of correlations between MSL and secondary outcomes. Between-group differences of MSL were assessed with the independent t-test.
The MSL exhibited excellent intrarater, interrater, and test-retest reliabilities [ICC: 0.885-1.000]. Significant correlations (: 0.447-0.723) were demonstrated between MSLs in most directions and muscle strengths of the affected legs, BBS scores, and walking speeds. The step lengths differed significantly between stroke survivors and healthy older adults in the forward, backward, and sideways directions on both the affected and less affected sides.
The MSL is a reliable, valid, and easily administered test of the stepping capabilities of stroke survivors. Stroke survivors had significant shorter MSLs in all directions than the age-matched healthy older adults.
本研究旨在:(1) 调查脑卒中幸存者最大步长测试(MSL)的组内、组间和重测信度,以及最小可检测变化;(2) 检验 MSL 与脑卒中患者其他特定损伤测量的同时效度;(3) 比较脑卒中幸存者和年龄匹配的健康老年人在不同方向上的 MSL 表现。
交叉会话研究。
以大学为基础的研究实验室。
脑卒中幸存者(n=48)和年龄匹配的健康老年人(n=39)。
脑卒中幸存者在 1 个会话中由 2 名经过培训的评估者评估 MSL、下肢肌肉力量、稳定性极限(LOS)测试、Berg 平衡量表(BBS)、5 米步行测试和活动特定平衡信心(ABC)量表。1 周后,对他们的 MSL 表现进行重测,以建立重测信度。健康老年人仅接受 MSL 评估。组内相关系数(ICC)用于评估 MSL 的可靠性,Spearman 相关系数用于量化 MSL 与次要结果之间的相关性强度。使用独立 t 检验评估 MSL 之间的组间差异。
MSL 表现出优秀的组内、组间和重测信度[ICC:0.885-1.000]。MSL 与患侧和健侧的下肢肌肉力量、BBS 评分和行走速度之间存在显著相关性(r:0.447-0.723)。在患侧和健侧的前向、后向和侧向,脑卒中幸存者的步长明显短于年龄匹配的健康老年人。
MSL 是一种可靠、有效、易于实施的脑卒中患者跨步能力测试。脑卒中幸存者在所有方向上的 MSL 都明显短于年龄匹配的健康老年人。